B+
Bull case
25%
Probability
Target price
$7.25
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
RLMD
Relmada TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Encouraging NDV-01 Phase 2 results included a 95% complete-response rate at any time and 76% durable response at 12 months, while the balance sheet is positioned to support the planned program [#SEC-8K-2026-05-12] [#SEC-8K-2026-08-06].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -26.1.
What can break
Clinical and regulatory outcomes for NDV-01 and sepranolone remain binary and unproven.
Momentum
4
Value
41
Sentiment
77
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.20 · Bull $7.25 · Bear $2.75Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $12.40
Why
Momentum4 · Δ7d +0.2
Value41 · Δ7d 0.0
Sentiment77 · Δ7d -26.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -26.1.
Contradictions & invalidation
- • Clinical and regulatory outcomes for NDV-01 and sepranolone remain binary and unproven.
- • Further GMP manufacturing or stability delays could postpone the NDV-01 IND and Phase 3 program.
- • The expected NDV-01 timeline moved from mid-2026 in the May update to year-end 2026 in August, with GMP manufacturing and stability work still gating the IND [#SEC-8K-2026-05-12] [#SEC-8K-2026-08-06].
Catalyst clock
2026-12-31
NDV-01 IND filing and potential Phase 3 RESCUE initiation
Lead driver: Sentiment · See AI snapshot
Momentum
4
9% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
-1.5
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
77
62% active weight
Current posture
7d trendSoftening
Δ7d
-26.1
Δ21d
-21.6
Why this grade
Composite grade C. Momentum 4.1 / Value 41.2 / Sentiment 76.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$4.20
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$2.75
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$508.82M
Beta
0.78
Shares Out
106.67M
P/E (TTM) · Derived
-3.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-7.06
Rev YoY
-100.0%
EPS YoY
-61.4%
Gross Margin
+12.1%
Op Margin
-
Net Debt
-$93.01M
Current Ratio
29.52
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data